EcoDrugPlus

Glutamate Receptor, Ionotropic, Kainate 1a

Ensembl ID : ENSORLG00000004443
Gene Symbol: GRIK1A
3 Cross references
245 Possible Orthologues:

Glutamate Receptor, Metabotropic 2a

Ensembl ID : ENSORLG00000000763
Gene Symbol: GRM2A
3 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 2b

Ensembl ID : ENSORLG00000003328
Gene Symbol: GRM2B
4 Cross references
206 Possible Orthologues:

Glutamate Receptor, Metabotropic 3

Ensembl ID : ENSORLG00000009427
Gene Symbol: GRM3
4 Cross references
215 Possible Orthologues:

Glutamate Receptor, Metabotropic 5a

Ensembl ID : ENSORLG00000004517
Gene Symbol: GRM5A
4 Cross references
211 Possible Orthologues:

Glutamate Receptor, Metabotropic 5b

Ensembl ID : ENSORLG00000010875
Gene Symbol: GRM5B
4 Cross references
214 Possible Orthologues:

Glutaminase

Ensembl ID : ENSORLG00000015157
Gene Symbol: GLS
4 Cross references
232 Possible Orthologues:

Glutaminase Kidney Isoform, Mitochondrial

Ensembl ID : ENSORLG00000000151
Gene Symbol: LOC101175464
4 Cross references
230 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha A

Ensembl ID : ENSORLG00000007102
Gene Symbol: GSK3AA
4 Cross references
187 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha B

Ensembl ID : ENSORLG00000013330
Gene Symbol: GSK3AB
4 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSORLG00000017950
Gene Symbol: GSK3B
4 Cross references
221 Possible Orthologues:

Gonadotropin-Releasing Hormone Receptor 2

Ensembl ID : ENSORLG00000019757
Gene Symbol: GNRH-R2
3 Cross references
155 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).